Results 71 to 80 of about 12,401 (156)

HIV and CKD in the Tenofovir Era: A Prospective Parallel-Group Cohort Study From Tanzania

open access: yesKidney Medicine
Rationale & Objective: Longitudinal research on chronic kidney disease (CKD) in sub-Saharan Africa is sparse, especially among people living with HIV (PLWH).
Nicholas L.S. Roberts   +11 more
doaj   +1 more source

Efficacy and safety of tenofovir and entecavir in patients with chronic hepatitis B-related cirrhosis: a systematic review and meta-analysis

open access: yesFrontiers in Pharmacology
ObjectivesTo systematically evaluate the efficacy and safety of tenofovir and entecavir in chronic hepatitis B-related cirrhosis.MethodsA comprehensive search was conducted in databases including PubMed, Web of Science, Embase and Cochrane Library from ...
Lu Cao   +4 more
doaj   +1 more source

Health care providers' decision-making and early adoption of tenofovir alafenamide for HIV preexposure prophylaxis: An inductive qualitative study.

open access: yesPLoS ONE
BackgroundOver the past several years, there have been several changes affecting the available options for oral HIV preexposure prophylaxis, including approvals for tenofovir alafenamide with emtricitabine in 2019 and a generic formulation of tenofovir ...
Elisabeth Merchant   +3 more
doaj   +1 more source

Vaginal Microbiota and Cytokines Among Pregnant and Breastfeeding Women in Clinical Trials of the Dapivirine Vaginal Ring and Oral Tenofovir Disoproxil Fumarate/Emtricitabine. [PDF]

open access: yesOpen Forum Infect Dis
Petrina MAB   +10 more
europepmc   +1 more source

Prolonged QT Interval in HIV-1 Infected Humanized Mice Treated Chronically with Dolutegravir/Tenofovir Disoproxil Fumarate/Emtricitabine. [PDF]

open access: yesInt J Mol Sci
Namvaran A   +10 more
europepmc   +1 more source

HBV status modulates transaminase decrease after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in people with HIV. [PDF]

open access: yesJ Antimicrob Chemother
Lapadula G   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy